Name: Working Capital Turnover

Definition: Working capital turnover shows how efficiently the company uses its short-term resources — like cash, inventory, and receivables — to generate sales. Higher turnover means the company squeezes more sales from its working capital. Lower turnover may indicate inefficient inventory, slow collections, or too much short-term capital tied up unnecessarily.

Interpretation:
• In '2021', MEDP's working capital turnover was 8.54, showing how efficiently working capital is deployed. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at 1.36.
• In '2022', MEDP's working capital turnover was -8.70, showing how efficiently working capital is deployed. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at 0.60. Industry average declined by 0.76 from previous year.
• In '2023', MEDP's working capital turnover was -4.71, showing how efficiently working capital is deployed. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at 1.24. Industry average increased by 0.64 compared to previous year.
• In '2024', MEDP's working capital turnover was -10.37, showing how efficiently working capital is deployed. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at 2.10. Industry average increased by 0.87 compared to previous year.
Overall, MEDP's working capital turnover has been volatile but showed a downward trend over the past 4 years.

Formula: Working Capital Turnover = Net Sales / Working Capital

Good Range: Ranges 5-20 depending on business.